Pays: Royaume-Uni
Langue: anglais
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Epoprostenol sodium
pH10.5) for solution for infusion vials (Advanz Pharma
B01AC09
Epoprostenol sodium
500microgram
Powder and solvent for solution for infusion
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 02080100; GTIN: 5099602001664